---
title: "Aayush Wellness Ltd (539528) — Share Price, Financials & Analysis"
symbol: "539528"
company: "Aayush Wellness Ltd"
canonical: "https://tapetide.com/stocks/539528"
isin: "INE430R01023"
nse_symbol: "AAYUSHFOODANDHERBSLTD"
bse_code: "539528"
sector: "Food Products"
industry: "Packaged Foods"
market_cap_cr: 122.19
generated_at: "2026-09-13T18:27:43.305Z"
---

# Aayush Wellness Ltd (539528)

Canonical page: https://tapetide.com/stocks/539528

## Company

- **NSE Symbol:** AAYUSHFOODANDHERBSLTD
- **BSE Code:** 539528
- **ISIN:** INE430R01023
- **Sector:** Food Products
- **Industry:** Packaged Foods
- **Macro Sector:** Fast Moving Consumer Goods
- **Stock Type:** EQUITY
- **Listed Since:** 2015-12-31
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** aayushwellness.com

## About

Incorporated in 1984, Aayush Wellness Ltd provides nutraceutical, personalized health
care, preventive wellness, and digital health solutions[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:43:40.676143Z.

- **Market Cap:** ₹122.19 Cr
- **Classification:** Microcap
- **P/E (reported):** 30.1
- **EPS (TTM):** ₹0.84
- **Book Value:** ₹2.52
- **Price to Book:** 10.38
- **Dividend Yield:** 0.11%
- **ROE:** 40.64%
- **ROCE:** 40.77%
- **Debt to Equity:** 0.33
- **Revenue (yearly):** ₹155.48 Cr
- **Net Income:** ₹3.98 Cr
- **EBITDA:** ₹1.82 Cr
- **52-Week High:** ₹77.81
- **52-Week Low:** ₹21.2
- **RSI (14):** 53.14

## Tapetide Score

- **Score:** 49 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 43.6 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 76.83 | 9% |
| growth | 98.9 | 9% |
| momentum | 36.71 | 12% |
| ownership | 50 | 24% |
| quality | 48.85 | 22% |
| valuation | 25.04 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 36.9%

### Weaknesses

- Stock is trading at 9.94 times its book value
- Tax rate seems low
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.2.60 Cr.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 166.67% | -99.27% | -99.32% |
| ebitda margin growth | 40% | -75.05% | -98.38% | — |
| net income growth | 133.33% | 17.06% | 128% | 57% |
| revenue growth | -31.16% | 111.83% | 168% | 1% |
| roce | 43.43% | 240.32% | 240.32% | — |
| roe | 153.57% | 249.44% | 26.14% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.6 | 0 | 0 | 11.08 | 14.28 | 25.63 | 22.35 | 22.63 | 39.91 | 44.51 | 48.4 | 24.07 |
| Expenses | 0.36 | 0.03 | 0.23 | 10.84 | 13.36 | 24.54 | 21.26 | 22.12 | 39.34 | 44.12 | 48 | 23.51 |
| Operating Profit | 0.24 | -0.03 | -0.23 | 0.24 | 0.92 | 1.09 | 1.09 | 0.51 | 0.57 | 0.39 | 0.4 | 0.56 |
| OPM % | 40 | — | — | 2.17 | 6.44 | 4.25 | 4.88 | 2.25 | 1.43 | 0.88 | 0.83 | 2.33 |
| Other Income | 0.04 | 0.06 | 0.04 | 0.02 | 0 | 0 | 0.02 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.28 | 0.03 | -0.19 | 0.26 | 0.92 | 1.09 | 1.11 | 1.15 | 1.21 | 1.03 | 1.04 | 1.2 |
| Tax % | 0 | 0 | -10.53 | 0 | 0 | 0 | 0.9 | 0 | 0 | 0 | 41.35 | 0 |
| Net Profit | 0.28 | 0.03 | -0.17 | 0.26 | 0.92 | 1.09 | 1.1 | 1.16 | 1.21 | 1.03 | 0.62 | 1.2 |
| EPS in Rs | 0.06 | 0.01 | -0.03 | 0.05 | 0.19 | 0.22 | 0.23 | 0.24 | 0.25 | 0.21 | 0.13 | 0.25 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 188 | 132 | 127 | 152 | 17 | 8 | 1 | 73 | 155 | 157 |
| Expenses | 187 | 132 | 126 | 150 | 19 | 9 | 0 | 70 | 154 | 155 |
| Operating Profit | 1 | 0 | 2 | 2 | -2 | -1 | 0 | 3 | 2 | 2 |
| OPM % | 0.5 | -0.1 | 1.4 | 1.4 | -11 | -10 | 58 | 4.5 | 1.2 | 1.2 |
| Other Income | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 3 | 3 |
| Interest | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 1 | 1 | 1 | -2 | 0 | 1 | 3 | 4 | 4 |
| Tax % | 25 | 25 | 26 | 27 | -1 | 0 | 3 | 0 | 10 | — |
| Net Profit | 1 | 1 | 1 | 0 | -2 | 0 | 1 | 3 | 4 | 4 |
| EPS in Rs | 0.14 | 0.12 | 0.13 | 0.09 | -0.42 | -0.07 | 0.12 | 0.69 | 0.83 | 0.84 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 5 | 5 |
| Reserves | 1 | 2 | 3 | 3 | 4 | 2 | 1 | 2 | 3 | 7 |
| Borrowings | 1 | 0 | 1 | 12 | 2 | 5 | 0 | 0 | 0 | 4 |
| Other Liabilities | 11 | 37 | 29 | 29 | 27 | 1 | 0 | 0 | 0 | 1 |
| Total Liabilities | 16 | 43 | 35 | 46 | 36 | 11 | 4 | 5 | 9 | 17 |
| Fixed Assets | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Assets | 16 | 42 | 34 | 46 | 36 | 11 | 4 | 5 | 8 | 16 |
| Total Assets | 16 | 43 | 35 | 46 | 36 | 11 | 4 | 5 | 9 | 17 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -1 | 6 | -3 | -10 | 6 | -3 | 5 | -1 | 0 | -1 |
| Cash from Investing Activity | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Cash from Financing Activity | 1 | -1 | 1 | 11 | -9 | 3 | -5 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 4 | -2 | 1 | -3 | 0 | 0 | -1 | 0 | 0 |
| Free Cash Flow | -1 | 5 | -3 | -10 | 6 | -2 | 5 | -1 | 0 | -1 |
| CFO/OP | -465 | 738 | 3100 | -528 | 321 | 140 | -573 | -160 | 11 | -52 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 50 | 36 | 65 | 10 | 58 | 61 | 59 | 12 | 1 | 0 |
| Inventory Days | 7 | 37 | 23 | 120 | 25 | 136 | 0 | — | 1 | 2 |
| Days Payable | 45 | 78 | 83 | 89 | 72 | 17 | — | — | 1 | 1 |
| Cash Conversion Cycle | 11 | -6 | 5 | 40 | 11 | 180 | 59 | 12 | 1 | 1 |
| Working Capital Days | 17 | -1 | 9 | 40 | 19 | 181 | 96 | 268 | 3 | 2 |
| ROCE % | 12 | 23 | 20 | 15 | 14 | -15 | -5 | 13 | 51 | 36 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 9.99% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 1.05% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 25.99% | 22.3% | 20.78% | 20.73% | 21.17% | 28.4% | 25.18% | 25.66% | 40.99% | 42.56% | 47.42% | 49.07% |
| Others | 64.02% | 77.7% | 79.22% | 79.27% | 78.83% | 70.55% | 74.82% | 74.34% | 59.01% | 57.44% | 52.58% | 50.93% |
| No. of Shareholders | 2273 | 2133 | 2069 | 2345 | 5359 | 19637 | 18654 | 32632 | 46245 | 43444 | 42658 | 41157 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 3 / 7 / 9

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 27.14 | Sell |
| EMA (10) | 25.99 | Sell |
| SMA (20) | 24.97 | Buy |
| EMA (20) | 25.47 | Sell |
| SMA (50) | 24.35 | Buy |
| EMA (50) | 25.52 | Sell |
| SMA (100) | 28.03 | Sell |
| EMA (100) | 28.62 | Sell |
| SMA (200) | 33.05 | Sell |
| EMA (200) | 40.2 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 49.48 | Neutral |
| MACD (12,26,9) | 0.63 | Sell |
| Stochastic (14,3,3) | 37.87 | Neutral |
| ADX (14) | 25 | Neutral |
| Williams %R (14) | -66.52 | Neutral |
| ATR (14) | 2.33 | High Volatility |
| ROC (12) | 15.93 | Buy |
| Stoch RSI (14) | 35.28 | Neutral |
| UO (7,14,28) | 49.67 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 May - Aayush Wellness launched Dia Shield Tablets for diabetes and metabolic health on May 8, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 8 May - Aayush Wellness launched Dia Shield Tablets for diabetes and metabolic health on May 8, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9418f741-5c01-46cb-b977-74a31cac777d.pdf) |
| 4 Feb - Board meeting on Feb 12, 2026 to approve Q3/9M results ended Dec 31, 2025; trading window reopens 48 hours after. | [Board Meeting Intimation for Consideration Of Unaudited Financial Results As On December 31, 2025 4 Feb - Board meeting on Feb 12, 2026 to approve Q3/9M results ended Dec 31, 2025; trading window reopens 48 hours after.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4bf2b325-621d-42e2-a3e4-76670f79adf6.pdf) |
| 31 Mar - Appointed Dinesh Dhangare and Kashiram Jadhav as additional non-executive directors on 31 March 2026. | [Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, 31St March 2026. 31 Mar - Appointed Dinesh Dhangare and Kashiram Jadhav as additional non-executive directors on 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d4b84e95-bd3e-4601-91e2-712777d8bbd9.pdf) |
| 31 Mar - Appointed Dinesh Dhangare (DIN 11418438) and Kashiram Jadhav (DIN 11640980) as Additional Non-Executive Non-Independent Directors, 31 Mar 2026. | [Announcement under Regulation 30 (LODR)-Change in Directorate 31 Mar - Appointed Dinesh Dhangare (DIN 11418438) and Kashiram Jadhav (DIN 11640980) as Additional Non-Executive Non-Independent Directors, 31 Mar 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/37473148-bc4f-48e3-95e9-3da11829423d.pdf) |
| 30 Apr - April 30, 2026 disclosure: Aayush Wellness says large corporate norms are not applicable. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - April 30, 2026 disclosure: Aayush Wellness says large corporate norms are not applicable.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/afd11b90-7094-4e31-bf3d-bd5501d4a8e3.pdf) |
| 30 Apr - April 30, 2026 disclosure: Aayush Wellness says large corporate norms are not applicable. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - April 30, 2026 disclosure: Aayush Wellness says large corporate norms are not applicable.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/afd11b90-7094-4e31-bf3d-bd5501d4a8e3.pdf) |
| 25 Mar - Trading window closed from April 1, 2026; reopens 48 hours after audited financial results declaration. | [Closure of Trading Window 25 Mar - Trading window closed from April 1, 2026; reopens 48 hours after audited financial results declaration.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e6060e43-0e0c-4f94-b90f-b9450b77530c.pdf) |
| 24 Apr - Aayush Wellness launched Liver Detox Tablets on April 24, 2026, expanding its preventive healthcare portfolio. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 24 Apr - Aayush Wellness launched Liver Detox Tablets on April 24, 2026, expanding its preventive healthcare portfolio.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7cf5e6fc-1b7d-41f0-b380-395d2335ee5f.pdf) |
| 16h - Aayush Wellness launched Liver Detox Tablets on April 24, 2026, expanding its preventive healthcare portfolio. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 16h - Aayush Wellness launched Liver Detox Tablets on April 24, 2026, expanding its preventive healthcare portfolio.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7cf5e6fc-1b7d-41f0-b380-395d2335ee5f.pdf) |
| 14 Feb - Newspaper Advertisement pertaining to the Unaudited Financial Results for the quarter and nine months ended 31 December 2025 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Feb - Newspaper Advertisement pertaining to the Unaudited Financial Results for the quarter and nine months ended 31 December 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7869d368-5487-406c-9084-fbeab74c6ba3.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Resignation of Managing Director](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21182e74-af19-4484-8f76-3fd071e1a82e.pdf) |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eff2f43c-dd70-45a5-9d11-dc3ccebc777b.pdf) |
| 2026-09-07 | [Notice Of The 42Nd Annual General Meeting For The Financial Year 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8da8146-fcb1-44e9-bb85-993745edaf45.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11476bec-09cd-41d0-b457-82a1244498a1.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8250217e-16ec-41e2-93ed-42af34aa3a70.pdf) |
| 2026-09-03 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday September 03 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbf5e766-250c-41a5-9425-e757ae29c9b6.pdf) |
| 2026-09-01 | [Reply And Clarification On Price Movement Sought By BSE Limited](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdd3c83f-4c5f-4c90-9934-5b8eff9b1d59.pdf) |
| 2026-08-29 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c580f3ca-bd68-45f4-9516-dab40f6a4595.pdf) |
| 2026-08-19 | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dab13521-7877-4c42-8b29-adf2677cb631.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64b23b6e-2fbb-4e63-af41-81e620770386.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Un-Audited Standalone And Consolidated Financial Results Of For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1000e43d-228e-4eea-9484-6d930c74d2d4.pdf) |
| 2026-05-29 | [Results For The Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfdf2845-a84f-4e6e-94e4-5d2a895b93d7.pdf) |
| 2026-02-12 | [Financial Results As On 31 December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25c358ec-1856-422b-aa3b-7b41d0291c67.pdf) |
| 2025-11-13 | [Unaudited Financial Results As On 30.09.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=defced67-4a6e-4287-8c63-def4029422b8.pdf) |
| 2025-08-12 | [Outcome Of Board Meeting For The Quarter Ended June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=970d6522-becd-4ed1-8086-807fbb202e2a.pdf) |
| 2025-05-30 | [Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31/03/2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52bd6157-f753-4d45-8fb8-c18477aa385a.pdf) |
| 2025-02-13 | [Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended As On December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c408604f-6acf-47d2-97d7-ff74c7064342.pdf) |
| 2024-11-13 | [Outcome Of The Board Meeting Held On Wednesday, November 13, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=960211dc-92c8-45fd-9222-f64f58c1cdec.pdf) |
| 2024-08-12 | [Unaudited Financial Results For The Quarter Ended 30Th June 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b739193-8bdd-42e3-978e-ed9e99316937.pdf) |
| 2024-05-30 | [Financial Results For The Year Ended On March 31, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3308d3bd-adb8-4175-bef9-496f7ae2b439.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f37acf74-d297-4fa4-b2aa-669dd03c08d0.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/384f3457-710c-4ada-8e4a-febff7e5dc70.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6f62a7a4-f058-4f2d-8df8-44ff30255613.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539528/75646539528.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/539528/72701539528.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/539528/67219539528.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/539528/5395280319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/539528/5395280318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/539528/5395280317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/539528/5395280316.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:27:43.305Z.